Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
May 15, 2026Molecular MedicineOpen Access

TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression

View Full Paper
Ask AI
Bookmark
Share

Authors

ZJZhirong JiaXWXiang WuAOAorong Ouyang

Discussion

Loading...

Member takes

Overview

Randomized trial reveals the role of TRMT6/TRMT61A in promoting leukemogenesis in AML, suggesting potential targeted therapy strategies.

Key Points

  • This research aims to elucidate the role of TRMT6/TRMT61A in tRNA m1A methylation and its impact on AML progression.
  • Functional assays conducted in vitro and in vivo to assess the role of TRMT6/TRMT61A in AML.
  • Evaluation of TRMT6/TRMT61A expression levels in AML and their correlation with patient prognosis.
  • Use of knockdown techniques to analyze effects on proliferation and apoptosis in AML cells.
  • TRMT6/TRMT61A was significantly upregulated in AML, correlating with poor prognosis.
  • TRMT6/61A knockdown in AML cells inhibited proliferation and induced apoptosis.
  • In mouse xenograft models, TRMT6/61A knockdown reduced tumor burden and improved survival.

Cite This Study

Jia et al. (2026) studied this question.

synapsesocial.com/papers/6a06b888e7dec685947ab042https://doi.org/10.1186/s10020-026-01496-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells2025 · 8 citations
  2. 2RNA m 1 A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target2025 · 7 citations
  3. 3WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis2025 · 3 citations
  4. 4Targeting METTL3 disrupts oncogenic transcriptional programs and activates immune and apoptotic pathways in Acute Myeloid Leukemia2025
  5. 5Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia2025 · 1 citations